|AHFS/Drugs.com||Consumer Drug Information|
|Elimination half-life||15-40 hours|
|Chemical and physical data|
|3D model (JSmol)|
Secobarbital sodium (marketed by Eli Lilly and Company, and subsequently by other companies as described below, under the brand name Seconal) is a barbiturate derivative drug that was patented in 1934 in the United States. It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as quinalbarbitone. It is the most frequently used drug in physician-assisted suicide within the United States.
Secobarbital is indicated for:
- Treatment of epilepsy
- Temporary treatment of insomnia
- Use as a preoperative medication to produce anaesthesia and anxiolysis in short surgical, diagnostic, or therapeutic procedures which are minimally painful.
Ranbaxy Pharmaceuticals, an India-based company now predominantly owned by the Japanese company Daiichi Sankyo, obtained the rights to market and to use the trade name “Seconal” from Eli Lilly in 1998 and did so until September 18, 2008. The actual manufacturer of Seconal subsequent to the time Eli Lilly manufactured the drug was Ohm Pharmaceuticals, a wholly owned subsidiary of Ranbaxy. The rights to market Seconal were then sold to Marathon Pharmaceuticals, which became the marketer and trade-name holder. At the time Marathon Pharmaceuticals obtained ownership of the brand name, the retail price for one 100 mg. capsule (depending upon prescription size and pharmacy) averaged about one U.S. dollar. During the time Marathon owned the brand name, the Company greatly increased the price of the drug. By February 2015, when Marathon sold the rights to Valeant Pharmaceuticals, the average retail price per 100 mg. capsule had risen to over thirty dollars. Since its acquisition of the trade name, Valeant Pharmaceuticals made little, if any, change to the pricing of Seconal. Despite the price increases implemented by Marathon Pharmaceuticals, Seconal was still manufactured by Ohm. In the United States, Seconal is available only in 100 mg capsules, as a sodium salt. The salt is a white hygroscopic powder that is soluble in water and ethanol.
While generic versions of the drug were in existence after Eli Lilly's patent of the name Seconal expired, currently there are no companies that manufacture the drug generically in the United States. Valeant is now the sole marketer of Seconal in the United States.
The sodium salt of secobarbital is classified separately from the free acid, as follows:
- CAS number: 309-43-3
- Chemical formula: C12H18N2NaO3
- Molecular weight: 260.265
Possible side effects of secobarbital include:
- Impaired motor functions
- Impaired coordination
- Impaired balance
- Agitation, irritability, or excitability
- Increased sensitivity to pain
- Allergic reactions
Secobarbital may produce psychological addiction and produces physical dependence if used for an extended period of time. Withdrawal symptoms may occur if long-term use is abruptly ended and can include:
- Lack of appetite
- Possible death as a result of withdrawal
Secobarbital was widely used for recreational purposes in the 1960s and 1970s, and accidental overdose was associated with the drug. Prescription use of secobarbital decreased beginning in the early 1980s by which time benzodiazepines had become increasingly common. Secobarbital has acquired many nicknames, the most common being “reds,” “red devils,” or “red dillies” (because of the color of the capsules). Other common nicknames are “seccies,” “Cardinals,” “ruby slippers,” and, according to the Wegman’s School of Pharmacy curriculum, “red hearts.” A less common nickname is “dolls”; this was partly responsible for the title of Jacqueline Susann’s novel Valley of the Dolls, whose main characters use secobarbital and other such drugs. Actress Carole Landis, after a life of depression and failed marriages, overdosed on secobarbital in 1948. 
Use in animal and human euthanasia
In the Netherlands, individuals have two options for euthanasia. They can orally consume 100 ml of concentrated syrup containing either 15 grams of pentobarbital or 15 grams of secobarbital, or they can choose to have 2 grams of thiopental or 1 gram of propofol administered intravenously by a doctor, followed by a muscle relaxant. In recent years only 15% of those who died by euthanasia opted for orally consuming the lethal drug(s), the rest choosing to have the drugs administered intravenously by a doctor instead.
In the United States, secobarbital and pentobarbital are the most common drugs prescribed under physician aid-in-dying laws in Oregon since 1998, Washington since 2008, and Vermont since 2013.  Ranbaxy Laboratories Limited previously experienced various issues in their attempts to produce 100 mg secobarbital capsules.
- Lexi-Comp. "Secobarbital". Archived from the original on 2007-12-02.
- US patent 1954429, Shonle, H. A., "Propyl-Methyl Carbinyl Allyl Barbituric Acid and its Salts", issued 1934-04-10, assigned to Eli Lilly
- Dembosky, April. "Drug Company Jacks Up Cost Of Aid-In-Dying Medication". NPR.org. Archived from the original on 2016-03-23. Retrieved 2016-03-24.
- "» Seconal Sodium®". Marathonpharma.com. 2013-07-31. Archived from the original on 2012-06-28. Retrieved 2014-03-05.
- "Marathon Pharma to Focusing Exclusively on Rare Disease". Marathon Pharmaceuticals, LLC. Archived from the original on 2016-03-29. Retrieved 2016-03-24.
- "Seconal Sodium - FDA prescribing information, side effects and uses". www.drugs.com. Archived from the original on 2016-04-07. Retrieved 2016-03-24.
- "The dark side of Los Angeles: crime and corruption in Tinseltown – in pictures". 21 February 2018. Archived from the original on 24 April 2018 – via www.theguardian.com.
- unknown; et al. (July 29, 2010). "Hulp bij zelfdoding(Dutch)". Oncoline. Archived from the original on June 29, 2016.
- Heleen Croonen; et al. (April 1, 2010). "Euthanasiedrank verliest terrein(Dutch)". Medisch contact.
- Elizabeth Trice Loggers, M.D., Ph.D; et al. (April 11, 2013). "Implementing a Death with Dignity Program at a Comprehensive Cancer Center". New England Journal of Medicine. Archived from the original on November 4, 2014.
- "Oregon's Death with Dignity Act 2013 Report" (PDF). Oregon Health Authority. January 28, 2014. Archived (PDF) from the original on November 18, 2014.
- Katrina Hedberg, M.D., M.P.H.; et al. (March 6, 2003). "Five Years of Legal Physician-Assisted Suicide in Oregon". New England Journal of Medicine. Archived from the original on November 4, 2014.
- NIH. "Secobarbital - Human Health Effects". Archived from the original on 2018-02-22.